RTX A/S (CPH:RTX)
Denmark · Delayed Price · Currency is DKK | Market Cap | 744.75M +13.8% |
| Revenue (ttm) | 581.68M +2.0% |
| Net Income | 12.11M +12.8% |
| EPS | 1.50 +12.8% |
| Shares Out | 7.84M |
| PE Ratio | 63.29 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,652 |
| Open | 96.00 |
| Previous Close | 96.00 |
| Day's Range | 95.00 - 96.80 |
| 52-Week Range | 81.20 - 120.00 |
| Beta | 1.33 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 27, 2026 |
About RTX A/S
RTX A/S, a technology company, designs, manufactures, and sells wireless communication solutions in Denmark, France, Germany, rest of Europe, the United States, Hong Kong, Other Asia and Pacific, and internationally. It operates through three segments: Enterprise, ProAudio, and Healthcare. The company designs, develops, and manufactures wireless IP telephony products and sub-systems, including headsets, handsets, base stations, repeaters, location beacons, and cloud-based deployment and device management tools. It also provides microphone and i... [Read more]
Financial Performance
Financial StatementsNews
RTX A/S Quarterly report: Q2 2026
RTX A/S has published its Q2 2026 quarterly earnings report on May 19, 2026.
RTX A/S Slides: Q2 2026
RTX A/S has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on May 19, 2026.
RTX A/S Transcript: Q2 25/26
Revenue grew 2% year-on-year (11% underlying), with strong Healthcare and ProAudio driving higher gross margins and EBITDA. Memory shortages from AI demand pose risks to supply and pricing, but full-year guidance is maintained and investments focus on Healthcare and Enterprise platform growth.
RTX A/S Quarterly report: Q2 2026
RTX A/S has published its Q2 2026 quarterly earnings report on May 18, 2026.
RTX A/S Slides: Q2 2026
RTX A/S has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on May 18, 2026.
RTX A/S Quarterly report: Q1 2026
RTX A/S has published its Q1 2026 quarterly earnings report on February 3, 2026.
RTX A/S Slides: Q1 2026
RTX A/S has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on February 3, 2026.
RTX A/S Transcript: Q1 25/26
Q1 saw 7% revenue growth to DKK 108 million, driven by strong Healthcare and ProAudio performance, with gross margin rising to 55%. Full-year guidance is maintained, supported by a robust order book and positive market trends in key segments.
RTX A/S Quarterly report: Q1 2026
RTX A/S has published its Q1 2026 quarterly earnings report on January 30, 2026.
RTX A/S Slides: Q1 2026
RTX A/S has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on January 30, 2026.
RTX A/S Annual report: Q4 2025
RTX A/S has published its Q4 2025 annual report on December 2, 2025.
RTX A/S Slides: Q4 2025
RTX A/S has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on December 2, 2025.
RTX A/S Transcript: Q4 24/25
Revenue grew 10% year-over-year, with strong gains in enterprise and healthcare, and gross margin improved by 3.3 points. Guidance for next year anticipates further revenue and EBITDA growth, supported by investments in healthcare, retail, and next-gen platforms.
RTX A/S Annual report: Q4 2025
RTX A/S has published its Q4 2025 annual report on November 28, 2025.
RTX A/S Slides: Q4 2025
RTX A/S has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on November 28, 2025.
RTX A/S Transcript: Q3 24/25
Revenue and profitability grew in Q3, led by enterprise and healthcare, despite currency headwinds. Guidance was raised and narrowed, with strong liquidity enabling a share buyback. ProAudio is transitioning to a scalable model, and supply chain diversification continues.
RTX A/S Quarterly report: Q3 2025
RTX A/S has published its Q3 2025 quarterly earnings report on August 29, 2025.
RTX A/S Slides: Q3 2025
RTX A/S has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on August 29, 2025.